Complications of immunotherapy in advanced hepatocellular carcinoma
Immune checkpoint inhibitors (ICIs) are highly effective in cancer treatment. However, the risks associated with the treatment must be carefully balanced against the therapeutic benefits. Immune-related adverse events (irAEs) are generally unpredictable and may persist over an extended period. In th...
Saved in:
Main Authors: | Young-Gi Song (Author), Jeong-Ju Yoo (Author), Sang Gyune Kim (Author), Young Seok Kim (Author) |
---|---|
Format: | Book |
Published: |
Korean Liver Cancer Association,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma
by: So Young Yoo, et al.
Published: (2017) -
Immunotherapies for advanced hepatocellular carcinoma
by: Li-Yang Sun, et al.
Published: (2023) -
Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study
by: Sun Hong Yoo, et al.
Published: (2023) -
A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
by: Yu Rim Lee
Published: (2023) -
Immunotherapy in Hepatocellular Carcinoma
Published: (2023)